GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Capital Expenditure

Pharmarise Holdings (TSE:2796) Capital Expenditure : 円0.00 Mil (TTM As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Pharmarise Holdings's cash flow for capital expenditures for the three months ended in Feb. 2024 was 円0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Feb. 2024 was 円0.00 Mil.

Pharmarise Holdings Capital Expenditure Historical Data

The historical data trend for Pharmarise Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Capital Expenditure Chart

Pharmarise Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -458.00 -457.00 -552.00 -466.00 -542.00

Pharmarise Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharmarise Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmarise Holdings (TSE:2796) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Capital Expenditure
Comparable Companies
TSE:9776 TSE:7129 TSE:3544 TSE:3417 TSE:4350 TSE:2934 WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391 TSE:3141 JSE:CLS TSE:9989 TSE:7649
Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Website
http://www.pharmarise.com
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines